Skip to content

Eton Pharmaceuticals, Inc. ETON Other Working Capital

Other Working Capital at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$341K-48.6%
XER
Xeris Biopharma Holdings, Inc.XERS
$0-100%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$1M-200%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$0-100%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$4K-99.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$306K-1,557%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s other working capital?
Eton Pharmaceuticals, Inc. (ETON) reported other working capital of -$7K in Q1 2026.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.